<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; 07-2009 (July 2009)</title>
	<atom:link href="http://www.jcadonline.com/category/issue-archives/07-2009-july-2009/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Thu, 19 Jan 2012 16:38:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Long-term Follow up of Diclofenac  Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation</title>
		<link>http://www.jcadonline.com/long-term-follow-up-of-diclofenac-sodium-3-in-25-hyaluronic-acid-gel-for-actinic-keratosis-one-year-evaluation/</link>
		<comments>http://www.jcadonline.com/long-term-follow-up-of-diclofenac-sodium-3-in-25-hyaluronic-acid-gel-for-actinic-keratosis-one-year-evaluation/#comments</comments>
		<pubDate>Fri, 03 Jul 2009 21:02:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[07-2009 (July 2009)]]></category>
		<category><![CDATA[Actinic Keratosis]]></category>
		<category><![CDATA[Original Research]]></category>
		<category><![CDATA["cox 2 inhibitors" topical treatment rosacea]]></category>
		<category><![CDATA["darrell rigel" and "editorial board"]]></category>
		<category><![CDATA["tlns" actinic keratosis]]></category>
		<category><![CDATA[3% diclofenac 2.5% hyaluronan]]></category>
		<category><![CDATA[5-fu vs diclofenac]]></category>
		<category><![CDATA[a single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip]]></category>
		<category><![CDATA[actinic keratosis body severity index]]></category>
		<category><![CDATA[actinic keratosis chronic condition continuum prophylaxis]]></category>
		<category><![CDATA[actinic keratosis cryo treatment long term recurrent rate]]></category>
		<category><![CDATA[actinic keratosis diclofenac sodium]]></category>
		<category><![CDATA[actinic keratosis hyaluronic acid]]></category>
		<category><![CDATA[actinic keratosis score]]></category>
		<category><![CDATA[actinic keratosis treatment comparison diclofenac]]></category>
		<category><![CDATA[ak cyrotherapy v topical agents]]></category>
		<category><![CDATA[ak lesion score]]></category>
		<category><![CDATA[aktinic keratosis score]]></category>
		<category><![CDATA[allergy to diclofenac sodium cream 3%]]></category>
		<category><![CDATA[can actinic keratosis look worse in winter]]></category>
		<category><![CDATA[clinical assessment of actinic keratoses]]></category>
		<category><![CDATA[clinical measurement of actinic keratosis to treatment]]></category>
		<category><![CDATA[diclofanac sodium 3%]]></category>
		<category><![CDATA[diclofenac]]></category>
		<category><![CDATA[diclofenac 1% prophylaxis actinic keratoses]]></category>
		<category><![CDATA[diclofenac 3%]]></category>
		<category><![CDATA[diclofenac 3% gel in skin cancer]]></category>
		<category><![CDATA[diclofenac and hyaluronic acid]]></category>
		<category><![CDATA[diclofenac diethylammonium salt topical summary]]></category>
		<category><![CDATA[diclofenac gel 1% actinic keratosis]]></category>
		<category><![CDATA[diclofenac gel 1% for aks]]></category>
		<category><![CDATA[diclofenac gel 1% prevention of actinic keratosis]]></category>
		<category><![CDATA[diclofenac gel 1% prevention recurrent actinic keratosis]]></category>
		<category><![CDATA[diclofenac gel 1% recurrence of actinic keratosis]]></category>
		<category><![CDATA[diclofenac gel1% in actinic keratoses]]></category>
		<category><![CDATA[diclofenac hyaluronic acid eberle dermatology]]></category>
		<category><![CDATA[diclofenac long term]]></category>
		<category><![CDATA[diclofenac sodium 1 percent]]></category>
		<category><![CDATA[diclofenac sodium 3 per cent gel]]></category>
		<category><![CDATA[diclofenac sodium 3 vs. 5 fluroucil]]></category>
		<category><![CDATA[diclofenac sodium 3%]]></category>
		<category><![CDATA[diclofenac sodium 3% versus imiquimod]]></category>
		<category><![CDATA[diclofenac sodium as a course]]></category>
		<category><![CDATA[diclofenac sodium conclusion]]></category>
		<category><![CDATA[diclofenac sodium cream 3%]]></category>
		<category><![CDATA[diclofenac sodium gel evolution test]]></category>
		<category><![CDATA[diclofenac sodium gel for acitic keratosis]]></category>
		<category><![CDATA[diclofenac sodium in phase iii]]></category>
		<category><![CDATA[diclofenac sodium molecular changes]]></category>
		<category><![CDATA[diclofenac sodium skin cancer]]></category>
		<category><![CDATA[diclofenac sodium topical gel 1 acitinic]]></category>
		<category><![CDATA[diclofenac sodium topical gel 1.5%]]></category>
		<category><![CDATA[diclofenac sodium topical gel keratosis]]></category>
		<category><![CDATA[diclofenac sodium trial]]></category>
		<category><![CDATA[diclofenac sodium with hyauluronic acid]]></category>
		<category><![CDATA[diclofenac topical efficacy]]></category>
		<category><![CDATA[diclofenac vs fluorouracil]]></category>
		<category><![CDATA[diclofenaco gel]]></category>
		<category><![CDATA[diclofenan 3% topical gel and acnee marks]]></category>
		<category><![CDATA[dicofenlac sodium 3%]]></category>
		<category><![CDATA[how to calculate target lesion persantage]]></category>
		<category><![CDATA[hyaluronic acid efficacy]]></category>
		<category><![CDATA[hyaluronic acid gel long term effects in face]]></category>
		<category><![CDATA[hyaluronic acid to treat actinic keratosis]]></category>
		<category><![CDATA[imiquimod or diclofenac sodium 3% 2010 studies]]></category>
		<category><![CDATA[imiquimod verses diclofenac sodium gel]]></category>
		<category><![CDATA[immunohistochem cox-2 ear edema]]></category>
		<category><![CDATA[krawtchenko br j dermatol]]></category>
		<category><![CDATA[lesion number]]></category>
		<category><![CDATA[lesion score]]></category>
		<category><![CDATA[lésions actiniques gel diclofenac]]></category>
		<category><![CDATA[lesions follow up]]></category>
		<category><![CDATA[long term effect of sodium diclofenac]]></category>
		<category><![CDATA[long term effects of diclofenac]]></category>
		<category><![CDATA[long term effects of diclofenac sodium]]></category>
		<category><![CDATA[long term effects of diclofenic acid]]></category>
		<category><![CDATA[long term safety and efficacy study of diclofenac sodium]]></category>
		<category><![CDATA[long-term follow up of diclofenac sodium 3% in 2.5% hyaluronic acid gel for actinic keratosis]]></category>
		<category><![CDATA[long-term follow up of diclofenac sodium 3% in 2.5% hyaluronic acid gel for actinic keratosis: one-year evaluation.]]></category>
		<category><![CDATA[long-term follow up of diclofenac soduim]]></category>
		<category><![CDATA[management of field change in actinic keratosis]]></category>
		<category><![CDATA[microdermabrasion for pih]]></category>
		<category><![CDATA[multiple ak lesions number]]></category>
		<category><![CDATA[nycomed diclofenac hyaluronic]]></category>
		<category><![CDATA[peeling]]></category>
		<category><![CDATA[point score actinic keratosis]]></category>
		<category><![CDATA[point scores actinic keratosis]]></category>
		<category><![CDATA[post cryosurgery 3% diclofenac]]></category>
		<category><![CDATA[Pruritus]]></category>
		<category><![CDATA[psoriasis hyaluronic acid topical gel]]></category>
		<category><![CDATA[sattler et al.]]></category>
		<category><![CDATA[score diclofenac]]></category>
		<category><![CDATA[single target lesion]]></category>
		<category><![CDATA[sodium dicloflenac skin cancer]]></category>
		<category><![CDATA[solaraze gel 1% actinic keratosis following initial treatment]]></category>
		<category><![CDATA[solaraze gel 2.5% hyaluronic acid]]></category>
		<category><![CDATA[solaraze gel for keloid]]></category>
		<category><![CDATA[stockfleth 651 actinic]]></category>
		<category><![CDATA[studies on compliance of topical diclofenac gel]]></category>
		<category><![CDATA[studies on diclofenac sodium gel vs 5 fluorouracil]]></category>
		<category><![CDATA[sustained clearance rates for diclofenac]]></category>
		<category><![CDATA[target lesion]]></category>
		<category><![CDATA[target lesion assessment sarcoidosis]]></category>
		<category><![CDATA[target lesion assessment/score]]></category>
		<category><![CDATA[target lesion evaluation lesion description]]></category>
		<category><![CDATA[target lesion number score]]></category>
		<category><![CDATA[target lesion number score (tlns)]]></category>
		<category><![CDATA[target lesion number score (tlns) or cumulative lesion number score (clns). the]]></category>
		<category><![CDATA[target lesion number score (tlns), cumulative lesion number score (clns) and global improvement indices (gii).]]></category>
		<category><![CDATA[target lesion score]]></category>
		<category><![CDATA[target lesions on skin]]></category>
		<category><![CDATA[tlns diclofenac]]></category>
		<category><![CDATA[tlns target lesion number score]]></category>
		<category><![CDATA[topical 3% diclofenac in 2.5% hyaluronan gel 2011.]]></category>
		<category><![CDATA[treatment for target lessions]]></category>
		<category><![CDATA[voltaren gel compared to fu-5 for ak]]></category>
		<category><![CDATA[what is the target lesion score]]></category>
		<category><![CDATA[will actinic keratoses return after treatment with solaraze gel]]></category>

		<guid isPermaLink="false">http://www.jcadonline.com/?p=1683</guid>
		<description><![CDATA[Christopher Nelson, MD, University of South Florida, Tampa, Florida; Darrell Rigel, MD, New York University Medical Center, New York, New York Abstract Objective: To evaluate the long-term effects of treatment with diclofenac sodium 3% in 2.5% hyaluronic acid gel on clinically diagnosed actinic keratosis lesions in well-defined skin areas. Design: A one-year extension of a [...]]]></description>
		<wfw:commentRss>http://www.jcadonline.com/long-term-follow-up-of-diclofenac-sodium-3-in-25-hyaluronic-acid-gel-for-actinic-keratosis-one-year-evaluation/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

